Trial Profile
DP-R208 Pharmacokinetic Study Phase I
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Jun 2016
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil/rosuvastatin (Primary) ; Candesartan cilexetil; Rosuvastatin
- Indications Cardiovascular disorders
- Focus Pharmacokinetics
- Sponsors Alvogen
- 07 Jun 2016 Status changed from not yet recruiting to completed.
- 18 Mar 2016 New trial record